Meves Pharmaceuticals is Biotechnology in United States that focus on Thymidine Kinase business. Founded in 2016. They cover business area such as developer, nucleoside base therapy, severe genetic disease, mitochondrial disorder, specific tailoring, patient, condition, muscle, skeletal weakening, treatment, these rare and serious disorder.
2016
( 8 years old in 2024 )
Thymidine Kinase
-
57 West 57th Street
New York, NY 10019
United States
Private
developernucleoside base therapysevere genetic diseasemitochondrial disorderspecific tailoringpatientconditionmuscleskeletal weakeningtreatmentthese rare and serious disorder
* We use standard office opening hours in near Meves Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Meves Pharmaceuticals is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Meves Pharmaceuticals business is focusing on Thymidine Kinase.
Meves Pharmaceuticals headquarter office and corporate office address is located in 57 West 57th Street New York, NY 10019 United States.
Meves Pharmaceuticals was founded in United States.
In 2024, Meves Pharmaceuticals is currently focus on Thymidine Kinase sector.
Above is snippet of Google Trends for "Thymidine Kinase" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Meves Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
